Robert Maynor, MD
Ophthalmology · Huntsville, ALNPI 1497704175
Payments from drug & device makers
Across 62 payments — averaging $22.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$340
- AbbVie$233
- AstraZeneca$183
- Sun Pharmaceutical Industries Inc.$120
- Novartis$99
- Mallinckrodt Hospital Products Inc.$95
- plus $303 from 9 others
What the payments were for
- Food & beverage$1,372100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 16 | $340 |
| AbbVie(2 entities) | 10 | $233 |
| AstraZeneca | 6 | $183 |
| Sun Pharmaceutical Industries Inc. | 5 | $120 |
| Novartis | 5 | $99 |
| Mallinckrodt Hospital Products Inc. | 4 | $95 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $73 |
| Ocular Therapeutix, Inc. | 2 | $44 |
| Rxsight Inc | 2 | $42 |
| Tarsus Pharmaceuticals, Inc. | 2 | $36 |
| Bausch & Lomb Americas Inc. | 2 | $33 |
| Kala Pharmaceuticals, Inc. | 1 | $25 |
| Sight Sciences, Inc. | 1 | $19 |
| Oyster Point Pharma, Inc. | 1 | $17 |
| Thea Pharma Inc. | 1 | $15 |
How this compares
$1,372 in reported general payments places this provider in the 40th percentile of 197 ophthalmology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Timolol Maleate | 21 | $4,644 |
| Latanoprost | 130 | $2,128 |
| Brimonidine Tartrate | 12 | $1,700 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Huntsville
- Caroline WatsonHuntsville$292K
- John CoxHuntsville$118K
- Jonathan RamseyHuntsville$8K
- William MitchellHuntsville$8K
- Paul FrederickHuntsville$6K
- Robert FosterHuntsville$6K
- Patricia McCoyHuntsville$5K
- Robert StevensHuntsville$5K
- Walter HubickeyHuntsville$4K
- Sebastian HeersinkDothan$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.